matka guessing live AXS-05 Phase II/III trial for the treatment of Alzheimer's disease-related agitation has been accelerated to completion! New broad-spectrum antiviral drugs complementary to ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS. Regulators are due to ...

According to Phipps, the drugs currently available to treat Alzheimer’s have only eased the symptoms rather than stop its ...

State Sen. Catherine Blakespear wants to engage stakeholder groups to discuss possible changes to the law, but she faces ...

The Alzheimer’s epidemic continues to cast a shadow over the lives of millions. This disease erodes memories and cognitive ...

This University of Waterloo study shows how antipsychotic medications significantly worsened behavior in nursing home ...

What if the solution to Alzheimer’s disease lies not in combating the proteins that cause it, but in simply getting more ...

Even as new drugs come to market, further study appears to point to infections as a possible cause for the debilitating ...

LOUISVILLE – Six in 10 people living with dementia will wander at least once; many do so repeatedly. Wandering can be dangerous and life-threatening, weighing heavily on family and caregivers.

As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...

The Greater Kentucky/Southern Indiana chapter of the Alzheimer’s Association released some information about the research they’ve done in 2024. Here in Kentucky, they found that over 10% of adults age ...

Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for ...